Literature DB >> 16761114

Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women.

T Takeda1, K Tasaka, M Sakata, Y Murata.   

Abstract

To investigate the prevalence and impact of premenstrual symptoms in Japanese women, we developed the PSQ "The Premenstrual Symptoms Questionnaire" for the screening of premenstrual symptoms. The PSQ translates DSM-IV criteria into a rating scale with degrees of severity. One thousand one hundred and eighty-seven Japanese women between the ages of 20 and 49 yrs, who were seen at a clinic for uterine cancer screening, were assessed regarding their premenstrual symptoms using the PSQ. As many as 95% of these women were found to suffer from premenstrual symptoms. The rates of prevalence of moderate to severe PMS and PMDD in Japanese women were 5.3 and 1.2%, respectively, which are lower than those in Western women. Only 5.3% of women with moderate to severe PMS and PMDD were treated. The results of this study suggest that race and ethnicity influence the expression of premenstrual symptoms and that the current state of medical care for Japanese women with moderate to severe PMS and PMDD is not satisfactory.

Entities:  

Mesh:

Year:  2006        PMID: 16761114     DOI: 10.1007/s00737-006-0137-9

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  33 in total

1.  Prevalence, correlates, comorbidities, and suicidal tendencies of premenstrual dysphoric disorder in a nationwide sample of Korean women.

Authors:  Jin Pyo Hong; Subin Park; Hee-Ryung Wang; Sung Man Chang; Jee Hoon Sohn; Hong Jin Jeon; Hae Woo Lee; Seong-Jin Cho; Byung-Soo Kim; Jae Nam Bae; Maeng Je Cho
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-04-27       Impact factor: 4.328

2.  Premenstrual dysphoric disorder: evidence for a new category for DSM-5.

Authors:  C Neill Epperson; Meir Steiner; S Ann Hartlage; Elias Eriksson; Peter J Schmidt; Ian Jones; Kimberly A Yonkers
Journal:  Am J Psychiatry       Date:  2012-05       Impact factor: 18.112

3.  The complexity of premenstrual dysphoric disorder--risk factors in the population of Polish women.

Authors:  Violetta Skrzypulec-Plinta; Agnieszka Drosdzol; Krzysztof Nowosielski; Ryszard Plinta
Journal:  Reprod Biol Endocrinol       Date:  2010-11-14       Impact factor: 5.211

4.  The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women.

Authors:  S Gehlert; I H Song; C-H Chang; S A Hartlage
Journal:  Psychol Med       Date:  2008-03-26       Impact factor: 7.723

Review 5.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

6.  Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey.

Authors:  Julia Potter; Jean Bouyer; James Trussell; Caroline Moreau
Journal:  J Womens Health (Larchmt)       Date:  2009 Jan-Feb       Impact factor: 2.681

7.  Is premenstrual dysphoric disorder really a disorder?

Authors:  Tamara Kayali Browne
Journal:  J Bioeth Inq       Date:  2014-08-28       Impact factor: 1.352

8.  Fulfillment of the premenstrual dysphoric disorder criteria confirmed using a self-rating questionnaire among Japanese women with depressive disorders.

Authors:  Yoshiko Miyaoka; Yoshie Akimoto; Kayoko Ueda; Yuri Ujiie; Machiko Kametani; Yoko Uchiide; Toshiko Kamo
Journal:  Biopsychosoc Med       Date:  2011-05-02

9.  Screening of the pelvic organ prolapse without a physical examination; (a community based study).

Authors:  Fahimeh Ramezani Tehrani; Somayeh Hashemi; Masoumeh Simbar; Niloofar Shiva
Journal:  BMC Womens Health       Date:  2011-11-15       Impact factor: 2.809

10.  Menstrual cycle phase modulates emotional conflict processing in women with and without premenstrual syndrome (PMS)--a pilot study.

Authors:  Jana Hoyer; Inga Burmann; Marie-Luise Kieseler; Florian Vollrath; Lydia Hellrung; Katrin Arelin; Elisabeth Roggenhofer; Arno Villringer; Julia Sacher
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.